{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:45:25Z","timestamp":1787971525342,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.eimc.2015.03.001","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T19:22:13Z","timestamp":1427311333000},"page":"257-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vacunas antimeningoc\u00f3cicas. Situaci\u00f3n epidemiol\u00f3gica mundial y estrategias de prevenci\u00f3n mediante la vacunaci\u00f3n"],"prefix":"10.1016","volume":"33","author":[{"given":"Irene","family":"Rivero Calle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodriguez-Tenreiro S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Martin\u00f3n-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2015.03.001_bib0260","unstructured":"Centro Nacional de Epidemiologia. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiol\u00f3gica. Protocolos de enfermedades de declaraci\u00f3n obligatoria. Madrid, 2013."},{"key":"10.1016\/j.eimc.2015.03.001_bib0265","unstructured":"National Institute for Health and Clinical Excellence. Bacterial meningitis and meningococcal septicaemia. Management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care. NICE clinical guideline 102. National Collaborating Centre for Women's and Children's Health, 2010. Disponible en: http:\/\/www.nice.org.uk\/nicemedia\/live\/13027\/49339\/49339.pdf"},{"key":"10.1016\/j.eimc.2015.03.001_bib0270","series-title":"Enfermedades infecciosas. Principios y pr\u00e1ctica.","first-page":"2742","article-title":"Neisseria meningitidis","author":"Apicella","year":"2012"},{"key":"10.1016\/j.eimc.2015.03.001_bib0275","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1586\/erv.11.103","article-title":"Neisseria meningitidis B vaccines","volume":"10","author":"Panatto","year":"2011","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.eimc.2015.03.001_bib0280","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/adc.85.5.382","article-title":"Mortality in severe meningococcal disease","volume":"85","author":"Thorburn","year":"2001","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.eimc.2015.03.001_bib0285","unstructured":"Grupo de trabajo de la Gu\u00eda de Pr\u00e1ctica Cl\u00ednica sobre el Manejo de la Enfermedad Meningoc\u00f3cica Invasiva. Gu\u00eda de Pr\u00e1ctica Cl\u00ednica sobre el Manejo de la Enfermedad Meningoc\u00f3cica Invasiva. Ministerio de Sanidad, Servicios Sociales e Igualdad. Instituto Aragon\u00e9s de Ciencias de la Salud; 2013. Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el SNS: IACS N\u00b0 2011\/01."},{"key":"10.1016\/j.eimc.2015.03.001_bib0290","series-title":"La enfermedad meningoc\u00f3cica: pasado, presente y futuro.","year":"2013"},{"key":"10.1016\/j.eimc.2015.03.001_bib0295","unstructured":"Grupo de Trabajo MenB. Vacuna frente a enfermedad meningoc\u00f3cica invasora por serogrupo B y su posible utilizaci\u00f3n en salud p\u00fablica. Ponencia de Programas y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2013."},{"key":"10.1016\/j.eimc.2015.03.001_bib0300","unstructured":"European Centre for Disease Prevention and Control. Annual epidemiological report Reporting on 2011 surveillance data and 2012 epidemic intelligence data. 2013. Disponible en: http:\/\/www.ecdc.europa.eu\/en\/publications\/publications\/annual-epidemiological-report-2012.pdf"},{"key":"10.1016\/j.eimc.2015.03.001_bib0305","article-title":"The changing and dynamic epidemiology of meningococcal disease","author":"Halperin","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.03.001_bib0310","doi-asserted-by":"crossref","first-page":"e8347","DOI":"10.1371\/journal.pone.0008347","article-title":"Investigating the role of mitochondrial haplogroups in genetic predisposition to meningococcal disease","volume":"4","author":"Salas","year":"2009","journal-title":"PLoS One."},{"key":"10.1016\/j.eimc.2015.03.001_bib0315","unstructured":"European Centre for Disease Prevention and Control. Disponible en: http:\/\/www.ecdc.europa.eu\/en\/data-tools\/Pages\/home.aspx"},{"key":"10.1016\/j.eimc.2015.03.001_bib0320","first-page":"143","article-title":"Servicio de Vigilancia Epidemiol\u00f3gica. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. Comentario epidemiol\u00f3gico de las enfermedades de declaraci\u00f3n obligatoria y sistema de informaci\u00f3n microbiol\u00f3gica. Espa\u00f1a. 2012","volume":"21","year":"2013","journal-title":"Bolet\u00edn epidemiol\u00f3gico semanal."},{"key":"10.1016\/j.eimc.2015.03.001_bib0325","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1574-6976.2006.00052.x","article-title":"Lessons from meningococcal carriage studies","volume":"31","author":"Caugant","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.eimc.2015.03.001_bib0330","series-title":"Handbook of meningococcal disease.","first-page":"17","article-title":"The population biology of Neisseria meningitidis: implications for meningococcal disease, epidemiology and control","author":"Maiden","year":"2006"},{"key":"10.1016\/j.eimc.2015.03.001_bib0335","series-title":"Handbook of meningococcal disease.","first-page":"519","article-title":"Public health management","author":"Suart","year":"2006"},{"key":"10.1016\/j.eimc.2015.03.001_bib0340","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/IAI.73.4.2424-2432.2005","article-title":"Genetic Diversity and Carriage Dynamics of Neisseria lactamica in Infants","volume":"73","author":"Bennett","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.eimc.2015.03.001_bib0345","unstructured":"World Health Organization. Meningococcal meningitis. Fact sheet 141. November 2012. Updated February 2015, Disponible en: http:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/index.html"},{"key":"10.1016\/j.eimc.2015.03.001_bib0350","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1586\/14787210.2014.966079","article-title":"Prognostic markers of meningococcal disease in children: recent advances and future challenges","volume":"12","author":"Montero-Martin","year":"2014","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.eimc.2015.03.001_bib0355","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.0800151105","article-title":"Whole- genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis","volume":"105","author":"Schoen","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.eimc.2015.03.001_bib0360","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ng.640","article-title":"International Meningococcal Genetics Consortium. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease","volume":"42","author":"Davila","year":"2010","journal-title":"Nat Genet."},{"key":"10.1016\/j.eimc.2015.03.001_bib0365","doi-asserted-by":"crossref","unstructured":"Fraser, A. et al. Antibiotics for preventing meningococcal infections. The Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004785.pub2.","DOI":"10.1002\/14651858.CD004785.pub2"},{"key":"10.1016\/j.eimc.2015.03.001_bib0370","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.298.6673.569","article-title":"Does eradication of meningococcal carriage in household contacts prevent secondary cases of meningococcal disease?","volume":"298","author":"Stuart","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.eimc.2015.03.001_bib0375","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMra0906357","article-title":"Advances in the development of vaccines against Neisseria meningitidis","volume":"362","author":"Tan","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.03.001_bib0380","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1084\/jem.129.6.1385","article-title":"Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state","volume":"129","author":"Gotschlich","year":"1969","journal-title":"Journal of Experimental Medicine."},{"key":"10.1016\/j.eimc.2015.03.001_bib0385","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Artenstein. Human immunity to the meningococcus III. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"Exp Med"},{"key":"10.1016\/j.eimc.2015.03.001_bib0390","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI108235","article-title":"Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants","volume":"59","author":"Gold","year":"1975","journal-title":"J Clin Znvest."},{"key":"10.1016\/j.eimc.2015.03.001_bib0395","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3181\/00379727-157-39995","article-title":"Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, and Y","volume":"157","author":"Farquhar","year":"1978","journal-title":"Proc Soc Exp Biol Med."},{"key":"10.1016\/j.eimc.2015.03.001_bib0400","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3181\/00379727-169-41306","article-title":"Clinical and serological evaluation of a Meningococcal Polysaccharide Vaccine Groups A, C, Y and W-135","volume":"169","author":"Hankins","year":"1982","journal-title":"Proc Soc Exper Biol Med."},{"key":"10.1016\/j.eimc.2015.03.001_bib0405","first-page":"514","volume":"126","author":"Wyle","year":"1972","journal-title":"Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines J Infect Dis."},{"key":"10.1016\/j.eimc.2015.03.001_bib0410","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/INF.0b013e318282942f","article-title":"Commentary: European Medicines Agency recommends approval of a broadly protective vaccine against serogroup B meningococcal disease","volume":"32","author":"Granoff","year":"2013","journal-title":"Pediatr Infect Dis J."},{"issue":"Suppl 2","key":"10.1016\/j.eimc.2015.03.001_bib0415","first-page":"B1","volume":"30","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.03.001_bib0420","series-title":"Vacunas 2011.","first-page":"189","article-title":"Novedades en vacunolog\u00eda 2010","author":"Moraga Llop","year":"2012"},{"key":"10.1016\/j.eimc.2015.03.001_bib0425","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1473-3099(13)70037-9","article-title":"Novel assessment of a novel meningitis B vaccine","volume":"13","author":"Gill","year":"2013","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2015.03.001_bib0430","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"2001 Study Investigators. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2015.03.001_bib0435","first-page":"521","article-title":"Meningococcal vaccines: WHO position paper. November 2011","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec."},{"issue":"Suppl2","key":"10.1016\/j.eimc.2015.03.001_bib0440","first-page":"B37","article-title":"Meningococcal disease from the public health policy perspective","volume":"30","author":"Black","year":"2012","journal-title":"Vac- cine."},{"key":"10.1016\/j.eimc.2015.03.001_bib0445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2334-12-35","article-title":"Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection?. Experience from the Netherlands","volume":"12","author":"Kaaijk","year":"2012","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.eimc.2015.03.001_bib0450","unstructured":"European Centre for Disease Prevention and Control. Euvac net. http:\/\/ecdc.europa.eu\/en\/activities\/surveillance\/euvac\/schedules\/Pages\/schedules.aspx"},{"key":"10.1016\/j.eimc.2015.03.001_bib0455","unstructured":"JCVI statement on the use of meningococcal vaccines in the routine childhood immunisation programme.January2012http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@ab\/documents\/digitalasset\/dh_1324 43.pdf."},{"key":"10.1016\/j.eimc.2015.03.001_bib0460","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1696-2818(11)70008-7","article-title":"Vacuna universal frente a meningococo B","volume":"9","author":"Rodr\u00edguez-Tenreiro","year":"2011","journal-title":"An Pediatr Contin."},{"key":"10.1016\/j.eimc.2015.03.001_bib0465","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14712598.2011.585965","article-title":"Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles","volume":"11","author":"Bai","year":"2011","journal-title":"Expert Opin Biol Ther."},{"key":"10.1016\/j.eimc.2015.03.001_bib0470","unstructured":"Nissen MD, Marshall HS, Richmond P, Lambert SB, Roberton D, Gruber WC, et al. A randomized, placebo controlled, double-blind, phase 1 trial of ascending doses of meningococcal group rLP2086 vaccine. En: Proceedings of the 26th annual meeting of the European Society for Paedriatric Infectious Diseases. 2008."},{"key":"10.1016\/j.eimc.2015.03.001_bib0475","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1016\/j.vaccine.2014.07.049","article-title":"A randomized, phase 1\/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants","volume":"32","author":"Martinon-Torres","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.03.001_bib0480","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","article-title":"Reverse vaccinology, a genome-based approach to vaccine development","volume":"19","author":"Rappuoli","year":"2001","journal-title":"Vaccine."},{"issue":"Suppl 5","key":"10.1016\/j.eimc.2015.03.001_bib0485","first-page":"109","article-title":"Developing vaccines in the era of genomics: A decade of reverse vaccinology","volume":"18","author":"Seib","year":"2012","journal-title":"Clin MicrobiolInfect."},{"key":"10.1016\/j.eimc.2015.03.001_bib0490","doi-asserted-by":"crossref","unstructured":"Gil A, Barranco D, Batalla J, Bayas JM, Campins M, Gorrotxategi Gorrotxategi P, Lluch J, Martin\u00f3n-Torres F, Mellado MJ, Moreno-P\u00e9rez D, Uriel B, V\u00e1zquez JA. [Prevention of serogroup B meningococcal disease using a four-component vaccine.] An Pediatr (Barc). 2013 Oct 9. pii: S1695-4033(13)00169-0. doi: 10.1016\/j.anpedi.2013.04.013.","DOI":"10.1016\/j.anpedi.2013.04.013"},{"key":"10.1016\/j.eimc.2015.03.001_bib0520","unstructured":"Agencia Europea de Medicamentos (Web). Bexsero: vacuna antimeningoc\u00f3cica grupo B. Disponible: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_Product_Information\/human\/002333\/WC500137881.pdf"},{"key":"10.1016\/j.eimc.2015.03.001_bib0515","unstructured":"Grupo de Trabajo \u201cUso de 4CMenB en situaciones especiales\u201d, del Consejo Interterritorial del Sistema Nacional de Salud, Recomendaciones de utilizaci\u00f3n de la vacuna frente a enfermedad meningoc\u00f3cica por serogrupo B disponible en: http:\/\/www.sergas.es\/gal\/DocumentacionTecnica\/docs\/SaudePublica\/meningococica\/2_Recom_uso_4CMenB.pdf"},{"key":"10.1016\/j.eimc.2015.03.001_bib0505","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(13)62323-5","article-title":"Immunisation against meningococcus B: the case of Spain","volume":"382","author":"Martin\u00f3n-Torres","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2015.03.001_bib0510","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2014-306030","article-title":"Vaccine evaluation: lessons from a meningococcal B vaccine","author":"Sarfatti","year":"2015","journal-title":"Arch Dis Child."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T12:08:35Z","timestamp":1566475715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X15000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0213005X15000920"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2015.03.001","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vacunas antimeningoc\u00f3cicas. Situaci\u00f3n epidemiol\u00f3gica mundial y estrategias de prevenci\u00f3n mediante la vacunaci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2015.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}